CompletedNCT01181648
Long-Term Impact of Human Papillomavirus (HPV) on Quality of Life
Studying Squamous cell carcinoma of the oropharynx
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Principal Investigator
- Shrujal Baxi, MDMemorial Sloan Kettering Cancer Center
- Intervention
- questionnaire and semi-structured interviews(behavioral)
- Enrollment
- 210 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2010 – 2018
Study locations (6)
- Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
- Memorial Sloan Kettering West Harrison, Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre, New York, United States
- Memoral Sloan Kettering Cancer Center at Phelps, Sleepy Hollow, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01181648 on ClinicalTrials.govOther trials for Squamous cell carcinoma of the oropharynx
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06915038ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the OropharynxIndiana University
- RECRUITINGPHASE1NCT06747390Intratumoral Lidocaine Injection Before Oropharyngeal Cancer SurgeryRyan Carey
- RECRUITINGPHASE2NCT06702033The Minimalist Trial-2Washington University School of Medicine
- RECRUITINGPHASE1NCT06589609Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal CancerBlueSky Immunotherapies GmbH
- RECRUITINGPHASE2NCT06223568Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) CancerNational Cancer Institute (NCI)
- RECRUITINGPHASE2NCT05582122SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Post Therapeutic Surveillance of HPV16-driven Oropharyngeal CancersUNICANCER
- ACTIVE NOT RECRUITINGNCT06592716Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples?Rigshospitalet, Denmark
- RECRUITINGPHASE2NCT06323460Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal CancerOhio State University Comprehensive Cancer Center
See all trials for Squamous cell carcinoma of the oropharynx →